Pay in 4 interest-free payments of $38.67 Learn more
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11
2-dimethyl-2H-chromen-6-yl)-3-(thiophen-2-yl)prop-2-en-1-one
and increases the pH
Kunapuli SP
Epub 2014 Apr 27
The high BLU-554 liver-to-plasma ratio suggests there is a relatively high amount of the drug being transported into the liver
Satraplatin asib 2-dimethyl-2H-chromen-6-yl)-3-(thiophen-2-yl)prop-2-en-1-oneSatraplatin, also known as JM216 and BMS182751, is a platinum compound that is currently under investigation as one treatment of patients with advanced prostate cancer who have failed previous chemotherapy. It has not yet received approval from the U. S. Food and Drug Administration. First mentioned in the medical literature in 1993, satraplatin is the first orally active platinum based chemotherapeutic drug; other available platinum
US$ 139.50
US$ 20.00
US$ 95.00
US$ 349.50
US$ 65.95
US$ 1530.00
US$ 20.00